经颅磁刺激治疗耳鸣:利用耳鸣功能指数预测随机对照试验中的获益
本研究基于一项前瞻性、双盲、随机安慰剂对照试验的活性治疗组基线数据(n=35),受试者接受连续10个工作日的1 Hz经颅磁刺激(2000脉冲)。结果显示基线耳鸣功能指数(TFI)总分及8个分量表中的3个有助于区分应答者与非应答者,应答者基线耳鸣严重程度评分更高,但结论尚不明确,需大规模前瞻性研究。
要点
- 基线TFI总分及3个分量表有助于区分经颅磁刺激应答者与非应答者。
- 应答者基线耳鸣严重程度评分更高。
- 结论非确定性,需大规模前瞻性研究识别其他获益相关因素。
核心结论
- 与经颅磁刺激获益相关的主要因素是应答者基线耳鸣严重程度评分更高。
- TFI分量表有助于阐明导致基线严重程度评分更高的因素。
- 需大规模前瞻性研究采用系统方法识别和描述经颅磁刺激后耳鸣获益的其他相关因素。
研究设计与样本
- 分析来自前瞻性、双盲、随机安慰剂对照经颅磁刺激治疗耳鸣临床试验活性治疗组的基线数据(n=35)。
- 受试者为患有困扰性耳鸣的个体,接受连续10个工作日的1 Hz经颅磁刺激,每次2000脉冲。
- 主要结局指标为耳鸣功能指数(TFI),包含总分和8个分量表评分。
主要发现
- 基线TFI总分及8个分量表中的3个有助于区分经颅磁刺激应答者与非应答者。
- 应答者基线耳鸣严重程度评分更高。
- 上述发现并非确定性结论,但提示经颅磁刺激后感知获益的潜在因素。
局限性
- 原文指出这些发现并非确定性结论。
- 原文指出需要大规模前瞻性研究采用系统方法识别和描述经颅磁刺激后耳鸣获益的其他相关因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Identifying characteristics associated with transcranial magnetic stimulation (TMS) benefit would offer insight as to why some individuals experience tinnitus relief following TMS treatment, whereas others do not. The purpose of this study was to use the Tinnitus Functional Index (TFI) and its subscales to identify specific factors associated with TMS treatment responsiveness. METHODS: Individuals with bothersome tinnitus underwent 2000 pulses of 1-Hz TMS for 10 consecutive business days. The primary outcome measure was the TFI which yields a total score and eight individual subscale scores. Analyses were performed on baseline data from the active arm (n = 35) of a prospective, double-blind, randomized placebo-controlled clinical trial of TMS for tinnitus. RESULTS: Baseline total TFI score and three of the eight TFI subscales were useful in differentiating between responders and nonresponders to TMS intervention for tinnitus. These findings are not definitive, but suggest potential factors that contribute to perceived benefit following TMS. CONCLUSIONS: Overall, the main factor associated with TMS benefit was a higher tinnitus severity score for responders at baseline. The TFI subscales helped to clarify the factors that contributed to a higher severity score at baseline. Large-scale prospective research using systematic approaches is needed to identify and describe additional factors associated with tinnitus benefit following TMS. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT01104207 . Registered on 13 April 2010.
引用
- Theodoroff SM, Griest SE, Folmer RL, et al. Transcranial magnetic stimulation for tinnitus: using the Tinnitus Functional Index to predict benefit in a randomized controlled trial. Trials. 2017. PMID: 28183355. doi:10.1186/s13063-017-1807-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。